Built around measurable decisions
Danaher helps dental, laboratory, and imaging buyers convert innovation narratives into evidence gates, interoperability tests, and lifecycle controls.
Roadmap to 2030
These gates describe how a hospital or dental group can evaluate innovation. They are not release dates or regulatory claims for a specific Danaher SKU.
Treat Software Bill of Materials access, MDS² files, and coordinated disclosure contacts as procurement prerequisites for networked Class II/III devices.
Require bidirectional identity, observation, and order flows with Epic, Cerner, or MEDITECH in a non-production environment before go-live.
Where AI/ML or SaMD modules apply, document predetermined change control expectations, performance monitoring, and local validation ownership.
Separate hardware unboxing from remote configuration so field visits focus on physical safety, calibration, and acceptance testing.
Include energy telemetry, take-back certificates, and refresh cycles in capital planning—not as marketing claims, but as measurable facility inputs.
Context milestones
ISO 13485:2016 formalized risk-based quality-system expectations now central to supplier audits.
EU MDR 2017/745 and later IVDR reframed clinical evaluation and lifecycle obligations.
Cybersecurity and remote support became routine capital questions for networked devices.
FDA premarket cybersecurity guidance made SBOM and update planning procurement issues.
Teams evaluate devices, data pathways, service, and consumables as one operating system.
Interoperability ecosystem
These are stakeholder systems and standards, not partnership endorsements.
Co-development starts with constraints
Describe the current workflow, failure mode, intended users, data destination, and evidence required for a decision.
Start a pilot conversation